Cipla Limited (CIPLA) — Announcement

· NSE Neutral
📢 Key Event
Cipla's ESG rating downgraded to 64 by ESGRisk.ai
💡 Investor Takeaway
The downgrade could prompt investors to reassess Cipla's ESG risk profile and its impact on long-term valuation.
⚠️ Risks
ESG rating downgrade may signal heightened scrutiny of sustainability practices

Cipla announced that ESG rating provider ESGRisk.ai downgraded its ESG rating from 68 to 64, reflecting a re-evaluation of publicly available information and new data considered during the assessment period, with the update communicated on June 24, 2026.

📄 View Original Announcement (PDF)

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,15,682.55 Cr P/E: 25.4 ROE: 14.6% ROCE: 19.4%

View full CIPLA stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CIPLA — Free

Free account · 2 AI queries/day